These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17541428

  • 1. Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins.
    Wolter KG, Verhaegen M, Fernández Y, Nikolovska-Coleska Z, Riblett M, de la Vega CM, Wang S, Soengas MS.
    Cell Death Differ; 2007 Sep; 14(9):1605-16. PubMed ID: 17541428
    [Abstract] [Full Text] [Related]

  • 2. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
    Qin JZ, Xin H, Sitailo LA, Denning MF, Nickoloff BJ.
    Cancer Res; 2006 Oct 01; 66(19):9636-45. PubMed ID: 17018621
    [Abstract] [Full Text] [Related]

  • 3. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.
    Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V, Bennett F, Pollock PM, Trent JM, Hendrix MJ, Rizzo P, Miele L, Nickoloff BJ.
    Cancer Res; 2005 Jul 15; 65(14):6282-93. PubMed ID: 16024630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P, Loomis R, Carbone R, Srimatkandada S, Lacy J.
    Eur J Haematol; 2008 May 15; 80(5):407-18. PubMed ID: 18221384
    [Abstract] [Full Text] [Related]

  • 6. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U, von Metzler I, Kaiser M, Rosche M, Sterz J, Rötzer S, Rademacher J, Jakob C, Fleissner C, Kuckelkorn U, Kloetzel PM, Sezer O.
    Eur J Haematol; 2008 Feb 15; 80(2):133-42. PubMed ID: 18005386
    [Abstract] [Full Text] [Related]

  • 7. MYC-induced sensitivity of human malignant melanoma to proteasome inhibitors - a KaMYCaze effect.
    Fuchs SY.
    Pigment Cell Melanoma Res; 2008 Feb 15; 21(1):9-10. PubMed ID: 18353138
    [No Abstract] [Full Text] [Related]

  • 8. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
    Strauss SJ, Higginbottom K, Jüliger S, Maharaj L, Allen P, Schenkein D, Lister TA, Joel SP.
    Cancer Res; 2007 Mar 15; 67(6):2783-90. PubMed ID: 17363600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
    Fernández Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW, Lowe SW, Soengas MS.
    Cancer Res; 2005 Jul 15; 65(14):6294-304. PubMed ID: 16024631
    [Abstract] [Full Text] [Related]

  • 15. Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.
    von Metzler I, Heider U, Mieth M, Lamottke B, Kaiser M, Jakob C, Sezer O.
    Exp Cell Res; 2009 Aug 15; 315(14):2471-8. PubMed ID: 19410573
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
    Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K, Pal A, Bornmann WG, Chiao PJ, Huang P, Xiong H, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2006 Apr 01; 66(7):3773-81. PubMed ID: 16585204
    [Abstract] [Full Text] [Related]

  • 20. Bortezomib in combination with other therapies for the treatment of multiple myeloma.
    Orlowski RZ.
    J Natl Compr Canc Netw; 2004 Nov 01; 2 Suppl 4():S16-20. PubMed ID: 19791424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.